Sign in
Taking peoplePhase 3

STATIN-PRE trial

Key facts

Who runs it
Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Where
Spain6 sites in 1 countryChoose a country to see its sites
Status
Recruiting
Phase
Phase 3
People taking part
154 people, planned
Started
14 Jan 2026
Expected to end
31 Dec 2027
Type of study
Interventional
Record updated
14 August 2026

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Singleton fetus
  • Between 24+0 to 29+6 weeks of gestation at the inclusion
  • Early-onset severe PE: women with a diagnosis of severe-preterm PE who are candidates for expectant management and have no clinical indication for immediate delivery, based on the clinical assessments of the attending doctors
  • And/or IUGR: Diagnosis of early onset IUGR according to the SMFM classification with umbilical artery Doppler with absent/reversed diastolic flow; or estimated fetal weight <10th percentile plus pulsatility index (PI) of umbilical artery Doppler >95th percentil
  • Able to give informed consent

Who cannot take part

  • Treatment with pravastatin or other statins prior to inclusion
  • Abnormal karyotype, structural abnormalities, or congenital infections
  • Active liver disease, including persistent and unexplained elevations of serum transaminases (3 times above the upper limit)
  • Established maternal or fetal compromise that necessitated immediate delivery

This trial is currently available in Spain.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To assess that daily 40 mgr of oral administration of pravastatin in pregnant individuals with PE and/or IUGR between 24.0 and 29.6 weeks of gestation will prolong duration of pregnancy compared to conventional management.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Statin Intervention for Severe Early-Onset Placental Insufficiency: A Randomized Controlled Trial Assessing daily Administration as a Treatment Strategy (STATIN-PRE trial)
Record updated
14 August 2026